Affimed (NASDAQ:AFMD) Coverage Initiated at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of Affimed (NASDAQ:AFMD – Get Free Report) in a research report issued on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Affimed Stock Performance Shares of NASDAQ:AFMD opened at $0.93 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio […]
Stock analysts at StockNews.com assumed coverage on shares of Affimed (NASDAQ:AFMD – Get Free Report) in a research report issued on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Affimed Stock Performance Shares of NASDAQ:AFMD opened at $0.93 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio […]
